Objective To investigate predictive factors for irreversible organ damage in systemic
sclerosis (SSc) and establish a nomogram model. Methods This retrospective study included …

Background The clinical manifestations of SSc are highly heterogeneous, and there is still
no clinical predictive model that can accurately predict prognosis and guide treatment …

It is important for clinicians to determine the risk of worsening trajectories in SSc patients.
The Scleroderma Clinical Trials Consortium (SCTC) Damage Index (DI) has been …

Background: Systemic sclerosis (SSc) is a clinically heterogeneous and pathogenically
complex disease where disease activity and damage can occur simultaneously, making it …

Objective The clinical manifestations of systemic sclerosis (SSc) are highly variable,
resulting in varied outcomes and complications. Diverse fibrosis of the skin and internal …

Clinical predictors of mortality in systemic sclerosis (SSc) are diversely reported due to
different healthcare conditions and populations. A simple predictive model for early mortality …

Objectives To identify and appraise measures of disease status in systemic sclerosis (SSc).
Methods A systematic review of Medline (1966–2015), EMBASE (1974–2015), and …

Background Systemic sclerosis (ScS) has unpredictable course and high mortality.
Generalised Estimating Equations (GEE) is a technique useful for longitudinal data analysis …

The aims of the study were to determine prognostic factors for survival and causes of death
in a cohort of patients with systemic sclerosis (SSc). This was a cohort study of SSc patients …

Objective To develop a model that assesses the risk for progressive disease in patients with
systemic sclerosis (SSc) over the short term, in order to guide clinical management. Methods …